FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/11/060021 [Registered on: 20/11/2023] Trial Registered Prospectively
Last Modified On: 17/11/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparision of 2 drugs( hyperbaric bupivacaine and hyperbaric ropivacaine) used in spinal anaesthesia for caeserean section in patients with pregnancy induced hypertension
 
Scientific Title of Study   Comparison of hyperbaric ropivacaine and hyperbaric bupivacaine for Spinal Anaesthesia in Pregnancy Induced Hypertension (PIH) parturients undergoing Caesarean Section - A randomized controlled trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  RAJESHKUMAR N 
Designation  JUNIOR RESIDENT 
Affiliation  Jawaharlal Institute of Postgraduate Medical Education and Research 
Address  Department of Anaesthesiology and Critical care, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry-605006

Pondicherry
PONDICHERRY
605006
India 
Phone  9488997201  
Fax    
Email  drnrajeshkumar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr STALIN V 
Designation  Additional Professor 
Affiliation  Jawaharlal Institute of Postgraduate Medical Education and Research 
Address  Department of Anaesthesiology and Critical Care, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry-605006.

Pondicherry
PONDICHERRY
605006
India 
Phone  9786397762  
Fax    
Email  drvstalin@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr STALIN V 
Designation  Additional Professor 
Affiliation  Jawaharlal Institute of Postgraduate Medical Education and Research 
Address  Department of Anaesthesiology and Critical Care, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry-605006.

Pondicherry
PONDICHERRY
605006
India 
Phone  9786397762  
Fax    
Email  drvstalin@gmail.com  
 
Source of Monetary or Material Support  
Jawaharlal Institute of Postgraduate Medical Education and Research, Gorimedu, Dhanvantari Nagar, Puducherry-605006. 
 
Primary Sponsor  
Name  RAJESHKUMAR N 
Address  Junior Resident, Department of Anaesthesiology and Critical care, JIPMER, Puducherry-605006.  
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr RAJESHKUMAR N  Jawaharlal Institute of Postgraduate Medical Education and Research  Institute Block,2nd floor, Department of Anaesthesiology and critical care.
Pondicherry
PONDICHERRY 
9488997201

drnrajeshkumar@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE INTERVENTIONAL STUDIES CDSCO Reg. No. ECR/342/Inst/PY/2013/RR-19  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Hyperbaric Bupivacaine  Injection of 0.5% Hyperbaric Bupivacaine, 1.8 ml, during spinal anaesthesia, from injection of drug until the patient is shifted to recovery room and starts ambulation, duration 5 hours 
Intervention  Hyperbaric Ropivacaine  Injection of 0.75% Hyperbaric Ropivacaine, 1.8 ml, during spinal anaesthesia, from injection of drug until the patient is shifted to recovery room and starts ambulation, duration 5 hours 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  34.00 Year(s)
Gender  Female 
Details  Hypertensive disorders of pregnancy planned for elective caesarean section under Spinal Anaesthesia 
 
ExclusionCriteria 
Details  Hypersensitivity to any of the study drugs,
Patients with spinal deformity,
Patients with coagulopathy,
Short stature (less than 140 cms),
Elderly primigravida,
Precious pregnancy,
Other comorbidities like Diabetes Mellitus, CAD, Congenital heart diseases, Valvular heart diseases etc. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare the incidence of hypotension with Inj. 0.75% Hyperbaric Ropivacaine as compared to Inj. 0.5% Hyperbaric Bupivacaine during Spinal Anaesthesia for Caesarean Section in PIH   Untill patient is shifted to recovery room 
 
Secondary Outcome  
Outcome  TimePoints 
1)To compare the onset and regression of sensory block up to T10 between 2 groups.
2)To compare the onset and regression of motor block between 2 groups.
3)To compare incidence of side effects between 2 groups. 
untill regression of sensory block and motor block in recovery room 
 
Target Sample Size   Total Sample Size="146"
Sample Size from India="146" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   25/11/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Spinal anaesthesia or sub-arachnoid block (SAB), is commonly employed for caesarean sections. It is associated with various complications like hypotension and delayed ambulation. Presently Inj.0.5% hyperbaric bupivacaine is the most widely used drug for spinal anaesthesia. Though Inj. Hyperbaric Bupivacaine is widely used and very effective in Spinal Anaesthesia, it has the propensity to cause adverse hemodynamic effects. It is more lipophilic causing both sensory and motor blockade for prolonged duration. In today’s world, where minimal side effects and early ambulation are the demands of the hour, studies done with 0.5% ropivacaine made hyperbaric by addition of 25% dextrose have found it to be an alternative for Inj. Hyperbaric bupivacaine causing less cardiac side effects and providing early ambulation due to its sensorimotor dissociation and early regression.

Literature search shows studies have so far been done with prepared hyperbaric ropivacaine by anaesthesiologist under aseptic conditions. Commercially available Inj. 0.75% Hyperbaric Ropivacaine has been recently introduced in India and it has not been studied in PIH parturients.

Commercially available Inj. 0.75% Hyperbaric Ropivacaine provides reliable Spinal Anaesthesia as Inj. Hyperbaric Bupivacaine. Based on the results of the study, Inj. 0.75% Hyperbaric Ropivacaine can be a safer alternative to Inj.0.5% hyperbaric Bupivacaine in providing better hemodynamic profile and early ambulation.

 
Close